Autor: "Sun, M." - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Effects of social support, hope and resilience on depressive symptoms within 18 months after diagnosis of prostate cancer.
Autorzy:: Zhao X; Department of Hospice, Shengjing Hospital of China Medical University, Shenyang, 110004, China.
Sun M; Department of Urology, Shengjing Hospital of China Medical University, Shenyang, China.
Yang Y; Department of Ultrasound, Shengjing Hospital of China Medical University, Shenyang, China. .; Pokaż więcej
Źródło:: Health and quality of life outcomes [Health Qual Life Outcomes] 2021 Jan 07; Vol. 19 (1), pp. 15. Date of Electronic Publication: 2021 Jan 07.
Typ publikacji:: Journal Article
MeSH Terms:: Hope*
Resilience, Psychological*
Social Support*
Depression/*psychology
Prostatic Neoplasms/*psychology
Quality of Life/*psychology
Adult ; Cross-Sectional Studies ; Depression/etiology ; Humans ; Linear Models ; Male ; Middle Aged ; Prevalence ; Prostatic Neoplasms/diagnosis ; Regression Analysis ; Surveys and Questionnaires

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: The SIRT3 and SIRT6 Promote Prostate Cancer Progression by Inhibiting Necroptosis-Mediated Innate Immune Response.
Autorzy:: Fu W; Department of Pathology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, China.
Li H; Department of Pathology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, China.
Fu H; Department of Pathology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, China.
Zhao S; Department of Pathology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, China.
Shi W; Department of Pathology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, China.
Sun M; Department of Pathology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, China.
Li Y; Department of Pathology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, China.; Pokaż więcej
Źródło:: Journal of immunology research [J Immunol Res] 2020 Nov 17; Vol. 2020, pp. 8820355. Date of Electronic Publication: 2020 Nov 17 (Print Publication: 2020).
Typ publikacji:: Journal Article
MeSH Terms:: Immunity, Innate*/genetics
Necroptosis/*genetics
Necroptosis/*immunology
Prostatic Neoplasms/*genetics
Prostatic Neoplasms/*immunology
Sirtuin 3/*genetics
Sirtuins/*genetics
Biomarkers, Tumor ; Disease Progression ; Gene Expression Profiling ; Gene Expression Regulation, Neoplastic ; Humans ; Male ; Prognosis ; Promoter Regions, Genetic ; Prostatic Neoplasms/mortality ; Prostatic Neoplasms/pathology ; RNA, Messenger/genetics ; Receptor-Interacting Protein Serine-Threonine Kinases/genetics ; Sirtuin 3/metabolism ; Sirtuins/metabolism ; Transcriptome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Role of survivin expression in predicting biochemical recurrence after radical prostatectomy: a multi-institutional study.
Autorzy:: Mathieu R; Department of Urology, Medical University Vienna, General Hospital, Vienna, Austria.; Department of Urology, Rennes University Hospital, Rennes, France.
Lucca I; Department of Urology, Medical University Vienna, General Hospital, Vienna, Austria.; Department of Urology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
Vartolomei MD; Department of Urology, Medical University Vienna, General Hospital, Vienna, Austria.; Department of Cell and Molecular Biology, University of Medicine and Pharmacy, Targu Mures, Romania.
Mbeutcha A; Department of Urology, Medical University Vienna, General Hospital, Vienna, Austria.
Klatte T; Department of Urology, Medical University Vienna, General Hospital, Vienna, Austria.
Seitz C; Department of Urology, Medical University Vienna, General Hospital, Vienna, Austria.
Karakiewicz PI; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Centre, Montreal, Canada.
Fajkovic H; Department of Urology, Medical University Vienna, General Hospital, Vienna, Austria.
Sun M; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Centre, Montreal, Canada.
Lotan Y; Department of Urology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, USA.
Montorsi F; Department of Urology, Vita-Salute San Raffaele University, Milan, Italy.
Briganti A; Department of Urology, Vita-Salute San Raffaele University, Milan, Italy.
Rouprêt M; Assistance Publique-Hôpitaux de Paris, Academic Department of Urology, Faculté de Médecine Pierre et Marie Curie, La Pitié-Salpetrière Hospital, University Paris 6, Paris, France.
Margulis V; Department of Urology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, USA.
Rink M; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Rieken M; Department of Urology, University Hospital Basel, Basel, Switzerland.
Kenner L; Department of Pathology, Medical University Vienna, Vienna, Austria.
Susani M; Department of Pathology, Medical University Vienna, Vienna, Austria.
Wolgang L; Department of Urology, Krankenhaus der Barmherzigen Schwestern, Linz, Austria.
Shariat SF; Department of Urology, Medical University Vienna, General Hospital, Vienna, Austria.; Department of Urology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, USA.; Department of Urology, Weill Cornell Medical College, New York, NY, USA.; Pokaż więcej
Źródło:: BJU international [BJU Int] 2017 Feb; Vol. 119 (2), pp. 234-238. Date of Electronic Publication: 2016 Apr 05.
Typ publikacji:: Journal Article; Multicenter Study
MeSH Terms:: Prostatectomy*/methods
Inhibitor of Apoptosis Proteins/*biosynthesis
Neoplasm Recurrence, Local/*epidemiology
Prostatic Neoplasms/*metabolism
Prostatic Neoplasms/*surgery
Aged ; Humans ; Inhibitor of Apoptosis Proteins/analysis ; Male ; Middle Aged ; Neoplasm Recurrence, Local/blood ; Prognosis ; Prostate-Specific Antigen/blood ; Retrospective Studies ; Survivin

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Prognostic value of Caveolin-1 in patients treated with radical prostatectomy: a multicentric validation study.
Autorzy:: Mathieu R; Department of Urology, General Hospital, Vienna, Austria.; Department of Urology, Rennes University Hospital, Rennes, France.
Klatte T; Department of Urology, General Hospital, Vienna, Austria.
Lucca I; Department of Urology, General Hospital, Vienna, Austria.; Department of Urology, Centre hospitalier universitaire vaudois, Lausanne, Switzerland.
Mbeutcha A; Department of Urology, General Hospital, Vienna, Austria.
Seitz C; Department of Urology, General Hospital, Vienna, Austria.
Karakiewicz PI; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Centre, Montreal, QC, Canada.
Fajkovic H; Department of Urology, General Hospital, Vienna, Austria.
Sun M; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Centre, Montreal, QC, Canada.
Lotan Y; Department of Urology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, USA.
Scherr DS; Department of Urology, Weill Cornell Medical College, New York, NY, USA.
Montorsi F; Department of Urology, Vita-Salute San Raffaele University, Milan, Italy.
Briganti A; Department of Urology, Vita-Salute San Raffaele University, Milan, Italy.
Rouprêt M; Academic Department of Urology, La Pitié-Salpetrière Hospital, Assistance Publique-Hôpitaux de Paris, Faculté de Médecine Pierre et Marie Curie, University Paris 6, Paris, France.
Margulis V; Department of Urology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, USA.
Rink M; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Kluth LA; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Rieken M; Department of Urology, University Hospital Basel, Basel, Switzerland.
Kenner L; Clinical Institute of Pathology, Medical University Vienna, Vienna, Austria.; Ludwig Boltzmann Institute for Cancer Research, Vienna, Austria.; Unit of Pathology of Laboratory Animals (UPLA), University of Veterinary Medicine Vienna, Vienna, Austria.
Susani M; Clinical Institute of Pathology, Medical University Vienna, Vienna, Austria.
Robinson BD; Department of Urology, Weill Cornell Medical College, New York, NY, USA.; Department of Pathology, Weill Cornell Medical College, New York, NY, USA.
Xylinas E; Cochin Hospital, Assistance Publique-Hôpitaux de Paris, Paris Descartes University, Paris, France.
Loidl W; Department of Urology, Krankenhaus der Barmherzigen Schwestern, Linz, Austria.
Shariat SF; Department of Urology, General Hospital, Vienna, Austria.; Department of Urology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, USA.; Department of Urology, Weill Cornell Medical College, New York, NY, USA.; Pokaż więcej
Źródło:: BJU international [BJU Int] 2016 Aug; Vol. 118 (2), pp. 243-9. Date of Electronic Publication: 2015 Aug 13.
Typ publikacji:: Journal Article; Multicenter Study; Validation Study
MeSH Terms:: Prostatectomy*/methods
Caveolin 1/*biosynthesis
Prostatic Neoplasms/*metabolism
Prostatic Neoplasms/*surgery
Aged ; Caveolin 1/analysis ; Humans ; Male ; Middle Aged ; Prognosis ; Prostatic Neoplasms/chemistry ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Dose-dependent effect of androgen deprivation therapy for localized prostate cancer on adverse cardiac events.
Autorzy:: Schmid M; Division of Urologic Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Sammon JD; Vattikuti Urology Institute Center for Outcomes Research Analytics and Evaluation, Henry Ford Health System, Detroit, MI, USA.
Reznor G; Division of Urologic Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Kapoor V; Vattikuti Urology Institute Center for Outcomes Research Analytics and Evaluation, Henry Ford Health System, Detroit, MI, USA.
Speed JM; Division of Urologic Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Abdollah FA; Vattikuti Urology Institute Center for Outcomes Research Analytics and Evaluation, Henry Ford Health System, Detroit, MI, USA.
Sood A; Vattikuti Urology Institute Center for Outcomes Research Analytics and Evaluation, Henry Ford Health System, Detroit, MI, USA.
Chun FK; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Kibel AS; Division of Urologic Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Menon M; Vattikuti Urology Institute Center for Outcomes Research Analytics and Evaluation, Henry Ford Health System, Detroit, MI, USA.
Fisch M; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Sun M; Division of Urologic Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Trinh QD; Division of Urologic Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Pokaż więcej
Źródło:: BJU international [BJU Int] 2016 Aug; Vol. 118 (2), pp. 221-9. Date of Electronic Publication: 2015 Jul 22.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Gonadotropin-Releasing Hormone/*analysis
Heart Diseases/*etiology
Orchiectomy/*adverse effects
Postoperative Complications/*etiology
Prostatic Neoplasms/*drug therapy
Prostatic Neoplasms/*surgery
Aged ; Dose-Response Relationship, Drug ; Humans ; Life Expectancy ; Male ; Prostatic Neoplasms/mortality ; Survival Rate

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: A Surveillance, Epidemiology and End Results (SEER) database malfunction: perceptions, pitfalls and verities.
Autorzy:: Sun M; Center for Surgery and Public Health, Harvard Medical School, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, MA, USA.
Trinh QD; Center for Surgery and Public Health, Harvard Medical School, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, MA, USA.; Pokaż więcej
Źródło:: BJU international [BJU Int] 2016 Apr; Vol. 117 (4), pp. 551-2. Date of Electronic Publication: 2015 Aug 16.
Typ publikacji:: Letter
MeSH Terms:: Prostate-Specific Antigen/*blood
Prostatic Neoplasms/*diagnosis
SEER Program/*standards
Bias ; Humans ; Male ; Prognosis ; Reproducibility of Results

Opinia redakcyjna

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Early radiotherapy after radical prostatectomy improves cancer-specific survival only in patients with highly aggressive prostate cancer: validation of recently released criteria.
Autorzy:: Gandaglia G; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, Vita Salute San Raffaele University, Milan, Italy.
Karakiewicz PI
Briganti A
Trudeau V
Trinh QD
Kim SP
Montorsi F
Nguyen PL
Abdollah F
Sun M; Pokaż więcej
Źródło:: International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2015 Jan; Vol. 22 (1), pp. 89-95. Date of Electronic Publication: 2014 Aug 21.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Prostate/*pathology
Prostatectomy/*methods
Prostatic Neoplasms/*radiotherapy
Aged ; Aged, 80 and over ; Humans ; Male ; Middle Aged ; Neoplasm Grading ; Prostatic Neoplasms/mortality ; Prostatic Neoplasms/surgery ; Reproducibility of Results ; Risk Assessment ; Survival Analysis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: The impact of androgen-deprivation therapy (ADT) on the risk of cardiovascular (CV) events in patients with non-metastatic prostate cancer: a population-based study.
Autorzy:: Gandaglia G; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada.; Urological Research Institute, Vita-Salute San Raffaele University, San Raffaele Hospital, San Raffaele Scientific Institute, Milan, Italy.
Sun M; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada.
Popa I; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada.; Department of Urology, University of Montreal Health Center, Montreal, Canada.
Schiffmann J; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada.; Martini-clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany.
Abdollah F; Urological Research Institute, Vita-Salute San Raffaele University, San Raffaele Hospital, San Raffaele Scientific Institute, Milan, Italy.
Trinh QD; Division of Urologic Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Saad F; Department of Urology, University of Montreal Health Center, Montreal, Canada.
Graefen M; Martini-clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany.
Briganti A; Urological Research Institute, Vita-Salute San Raffaele University, San Raffaele Hospital, San Raffaele Scientific Institute, Milan, Italy.
Montorsi F; Urological Research Institute, Vita-Salute San Raffaele University, San Raffaele Hospital, San Raffaele Scientific Institute, Milan, Italy.
Karakiewicz PI; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada.; Department of Urology, University of Montreal Health Center, Montreal, Canada.; Pokaż więcej
Źródło:: BJU international [BJU Int] 2014 Dec; Vol. 114 (6b), pp. E82-E89. Date of Electronic Publication: 2014 Jul 27.
Typ publikacji:: Journal Article
MeSH Terms:: Orchiectomy*
Androgen Antagonists/*therapeutic use
Coronary Disease/*epidemiology
Death, Sudden, Cardiac/*epidemiology
Myocardial Infarction/*epidemiology
Prostatic Neoplasms/*drug therapy
Prostatic Neoplasms/*surgery
Aged ; Androgen Antagonists/adverse effects ; Cohort Studies ; Gonadotropin-Releasing Hormone/agonists ; Humans ; Male ; Propensity Score ; Prostatic Neoplasms/pathology ; Risk Factors ; SEER Program ; United States

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Survival benefit of definitive therapy in patients with clinically advanced prostate cancer: estimations of the number needed to treat based on competing-risks analysis.
Autorzy:: Gandaglia G; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada.; Department of Urology, Urological Research Institute, Vita Salute San Raffaele University, San Raffaele Scientific Institute, Milan, Italy.
Sun M; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada.
Trinh QD; Department of Surgery, Division of Urology, Brigham and Women's Hospital, Boston, USA.; Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.
Becker A; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada.; Martiniclinic, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Schiffmann J; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada.; Martiniclinic, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Hu JC; Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Briganti A; Department of Urology, Urological Research Institute, Vita Salute San Raffaele University, San Raffaele Scientific Institute, Milan, Italy.
Montorsi F; Department of Urology, Urological Research Institute, Vita Salute San Raffaele University, San Raffaele Scientific Institute, Milan, Italy.
Perrotte P; Department of Urology, University of Montreal Health Center, Montreal, Canada.
Karakiewicz PI; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada.; Department of Urology, University of Montreal Health Center, Montreal, Canada.
Abdollah F; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada.; Department of Urology, Urological Research Institute, Vita Salute San Raffaele University, San Raffaele Scientific Institute, Milan, Italy.; Pokaż więcej
Źródło:: BJU international [BJU Int] 2014 Dec; Vol. 114 (6b), pp. E62-E69. Date of Electronic Publication: 2014 Jul 15.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Numbers Needed To Treat*
Prostatectomy*
Watchful Waiting*
Prostatic Neoplasms/*mortality
Prostatic Neoplasms/*therapy
Aged ; Humans ; Male ; Neoplasm Grading ; Neoplasm Staging ; Propensity Score ; Prostatic Neoplasms/pathology ; Radiotherapy ; Risk Assessment ; SEER Program ; Survival Rate ; United States/epidemiology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Clinical nodal staging scores for prostate cancer: a proposal for preoperative risk assessment.
Autorzy:: Kluth LA; 1] Department of Urology, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, NY, USA [2] Department of Urology, University Medical-Center Hamburg-Eppendorf, Hamburg, Germany.
Abdollah F; Department of Urology, Vita-Salute San Raffaele University, Milan, Italy.
Xylinas E; 1] Department of Urology, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, NY, USA [2] Department of Urology, Cochin Hospital, Assistance Publique-Hopitaux de Paris, Paris Descartes University, Paris, France.
Rieken M; 1] Department of Urology, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, NY, USA [2] Department of Urology, University Hospital of Basel, Basel, Switzerland.
Fajkovic H; Department of Urology, Medical University of Vienna, Vienna, Austria.
Seitz C; Department of Urology, Medical University of Vienna, Vienna, Austria.
Sun M; Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada.
Karakiewicz PI; Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada.
Schramek P; Department of Urology, Krankenhaus der Barmherzigen Brueder, Vienna, Austria.
Herman MP; Department of Urology, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, NY, USA.
Becker A; Department of Urology, University Medical-Center Hamburg-Eppendorf, Hamburg, Germany.
Hansen J; Prostate Cancer Center, Martini-Clinic, Hamburg, Germany.
Ehdaie B; Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Loidl W; Prostate Cancer Center, Krankenhaus Barmherzige Schwestern Linz, Linz, Austria.
Pummer K; Department of Urology, Medical University of Graz, Graz, Austria.
Lee RK; Department of Urology, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, NY, USA.
Lotan Y; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Scherr DS; Department of Urology, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, NY, USA.
Seiler D; Department of Urology, Kantonsspital Aarau, Aarau, Switzerland.
Ahyai SA; Department of Urology, University Medical-Center Hamburg-Eppendorf, Hamburg, Germany.
Chun FK; Department of Urology, University Medical-Center Hamburg-Eppendorf, Hamburg, Germany.
Graefen M; Prostate Cancer Center, Martini-Clinic, Hamburg, Germany.
Tewari A; Department of Urology, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, NY, USA.
Nonis A; CUSSB (University Centre for Statistics in the Biomedical Sciences), Vita-Salute San Raffaele University, Milan, Italy.
Bachmann A; Department of Urology, University Hospital of Basel, Basel, Switzerland.
Montorsi F; Department of Urology, Vita-Salute San Raffaele University, Milan, Italy.
Gönen M; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Briganti A; Department of Urology, Vita-Salute San Raffaele University, Milan, Italy.
Shariat SF; 1] Department of Urology, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, NY, USA [2] Department of Urology, Medical University of Vienna, Vienna, Austria [3] Division of Medical Oncology, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, NY, USA.; Pokaż więcej
Źródło:: British journal of cancer [Br J Cancer] 2014 Jul 15; Vol. 111 (2), pp. 213-9. Date of Electronic Publication: 2014 Jul 08.
Typ publikacji:: Journal Article
MeSH Terms:: Prostatic Neoplasms/*pathology
Aged ; Aged, 80 and over ; Cohort Studies ; Humans ; Lymph Node Excision ; Lymphatic Metastasis ; Male ; Middle Aged ; Neoplasm Staging ; Prostatectomy ; Prostatic Neoplasms/surgery ; Risk Assessment

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Percentage of high-grade tumour volume does not meaningfully improve prediction of early biochemical recurrence after radical prostatectomy compared with Gleason score.
Autorzy:: Hansen J; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Martini Clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany.
Bianchi M
Sun M
Rink M
Castiglione F
Abdollah F
Steuber T
Ahyai SA
Steurer S
Göbel C
Freschi M
Montorsi F
Shariat SF
Fisch M
Graefen M
Karakiewicz PI
Briganti A
Chun FK; Pokaż więcej
Źródło:: BJU international [BJU Int] 2014 Mar; Vol. 113 (3), pp. 399-407. Date of Electronic Publication: 2013 Dec 02.
Typ publikacji:: Comparative Study; Journal Article
MeSH Terms:: Tumor Burden*
Neoplasm Recurrence, Local/*pathology
Prostatic Neoplasms/*pathology
Aged ; Cohort Studies ; Early Detection of Cancer/mortality ; Humans ; Kaplan-Meier Estimate ; Lymphatic Metastasis ; Male ; Middle Aged ; Neoplasm Grading ; Prostatectomy/methods ; Prostatectomy/mortality ; Prostatic Neoplasms/surgery ; Regression Analysis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Radical prostatectomy vs radiotherapy vs observation among older patients with clinically localized prostate cancer: a comparative effectiveness evaluation.
Autorzy:: Sun M; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada.
Sammon JD
Becker A
Roghmann F
Tian Z
Kim SP
Larouche A
Abdollah F
Hu JC
Karakiewicz PI
Trinh QD; Pokaż więcej
Źródło:: BJU international [BJU Int] 2014 Feb; Vol. 113 (2), pp. 200-8. Date of Electronic Publication: 2013 Aug 13.
Typ publikacji:: Comparative Study; Journal Article
MeSH Terms:: Prostatectomy*/statistics & numerical data
Watchful Waiting*/statistics & numerical data
Biomarkers, Tumor/*blood
Prostate-Specific Antigen/*blood
Prostatic Neoplasms/*radiotherapy
Prostatic Neoplasms/*surgery
Age Factors ; Aged ; Humans ; Male ; Medicare ; Neoplasm Staging ; Outcome Assessment, Health Care ; Prostatic Neoplasms/mortality ; Prostatic Neoplasms/pathology ; Radiotherapy/statistics & numerical data ; Risk Assessment ; Sentinel Surveillance ; United States/epidemiology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Targeting the neddylation pathway to suppress the growth of prostate cancer cells: therapeutic implication for the men's cancer.
Autorzy:: Wang X; Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai 200032, China ; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China ; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
Li L; Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai 200032, China ; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
Liang Y; Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai 200032, China ; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
Li C; Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai 200032, China ; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
Zhao H; Department of Laboratory Medicine, Laboratory of Molecular Biology of Huadong Hospital affiliated to Fudan University, Shanghai 200040, China.
Ye D; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Sun M; Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Jeong LS; College of Pharmacy, Seoul National University, Seoul, 151-742, Republic of Korea.
Feng Y; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Fu S; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Jia L; Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai 200032, China ; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
Guo X; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China ; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.; Pokaż więcej
Źródło:: BioMed research international [Biomed Res Int] 2014; Vol. 2014, pp. 974309. Date of Electronic Publication: 2014 Jun 29.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Molecular Targeted Therapy*
Cullin Proteins/*metabolism
Cyclopentanes/*administration & dosage
Prostatic Neoplasms/*genetics
Pyrimidines/*administration & dosage
Apoptosis/drug effects ; Cell Line, Tumor ; Cell Survival/drug effects ; DNA Damage/drug effects ; Humans ; Male ; Prostatic Neoplasms/drug therapy ; Prostatic Neoplasms/pathology ; Signal Transduction/drug effects ; Ubiquitin-Protein Ligases/antagonists & inhibitors ; Ubiquitins/metabolism

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Response to Re: Lymph node count threshold for optimal pelvic lymph node staging in prostate cancer.
Autorzy:: Abdollah F
Briganti A
Montorsi F
Karakiewicz PI
Sun M; Pokaż więcej
Źródło:: International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2013 Aug; Vol. 20 (8), pp. 845-6. Date of Electronic Publication: 2012 Dec 16.
Typ publikacji:: Letter; Comment
MeSH Terms:: Lymph Node Excision*
Neoplasm Staging*
Adenocarcinoma/*pathology
Lymph Nodes/*pathology
Lymph Nodes/*surgery
Prostatic Neoplasms/*pathology
Humans ; Male

Opinia redakcyjna

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Spatial distribution of positive cores improves the selection of patients with low-risk prostate cancer as candidates for active surveillance.
Autorzy:: Abdollah F; Department of Urology, Vita-Salute San Raffaele University, Milan, Italy. />Suardi N
Capitanio U
Gallina A
Sun M
Villa L
Scattoni V
Bianchi M
Tutolo M
Fossati N
Karakiewicz P
Rigatti P
Montorsi F
Briganti A; Pokaż więcej
Źródło:: BJU international [BJU Int] 2013 Aug; Vol. 112 (4), pp. E234-42. Date of Electronic Publication: 2013 Jun 07.
Typ publikacji:: Journal Article
MeSH Terms:: Patient Selection*
Watchful Waiting*
Prostatic Neoplasms/*pathology
Prostatic Neoplasms/*therapy
Humans ; Male ; Middle Aged ; Retrospective Studies ; Risk Factors

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Impact of the introduction of a robotic training programme on prostate cancer stage migration at a single tertiary referral centre.
Autorzy:: Briganti A; Department of Urology, Vita-Salute University, San Raffaele Scientific Institute, Milan, Italy. />Bianchi M
Sun M
Suardi N
Gallina A
Abdollah F
Bertini R
Colombo R
Girolamo VD
Salonia A
Scattoni V
Karakiewicz PI
Guazzoni G
Rigatti P
Montorsi F; Pokaż więcej
Źródło:: BJU international [BJU Int] 2013 Jun; Vol. 111 (8), pp. 1222-30. Date of Electronic Publication: 2012 Nov 13.
Typ publikacji:: Comparative Study; Journal Article
MeSH Terms:: Program Evaluation*
Tertiary Care Centers*
Education, Medical, Continuing/*methods
Prostatectomy/*education
Prostatic Neoplasms/*surgery
Robotics/*education
Urology/*education
Aged ; Humans ; Italy ; Male ; Middle Aged ; Neoplasm Staging ; Prostatectomy/methods ; Prostatic Neoplasms/pathology ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Response to Re: Comparison of mortality outcomes after radical prostatectomy versus radiotherapy in patients with localized prostate cancer: a population-based analysis.
Autorzy:: Abdollah F
Briganti A
Montorsi F
Karakiewicz PI
Sun M; Pokaż więcej
Źródło:: International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2013 May; Vol. 20 (5), pp. 548-9. Date of Electronic Publication: 2012 Dec 20.
Typ publikacji:: Letter; Comment
MeSH Terms:: Prostatectomy/*mortality
Prostatic Neoplasms/*mortality
Prostatic Neoplasms/*therapy
Radiotherapy/*mortality
Humans ; Male